Total Payments
$1,870
2024 Payments
$197.36
Companies
9
Transactions
64
Medicare Patients
697
Medicare Billing
$61,850
Payment Breakdown by Category
Food & Beverage$1,870 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,870 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,470 | 46 | $0 (2024) |
| Novo Nordisk Inc | $137.03 | 7 | $0 (2022) |
| Spine Wave, Inc. | $101.75 | 1 | $0 (2017) |
| Acella Pharmaceuticals, LLC | $57.63 | 4 | $0 (2019) |
| Nuvectra Corporation | $25.78 | 2 | $0 (2018) |
| Stryker Corporation | $23.38 | 1 | $0 (2022) |
| Integra LifeSciences Corporation | $23.30 | 1 | $0 (2019) |
| Antares Pharma, Inc. | $17.47 | 1 | $0 (2019) |
| PFIZER INC. | $14.12 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.36 | 5 | UCB, Inc. ($197.36) |
| 2023 | $116.86 | 4 | UCB, Inc. ($116.86) |
| 2022 | $101.48 | 4 | UCB, Inc. ($39.82) |
| 2021 | $337.93 | 13 | UCB, Inc. ($249.97) |
| 2020 | $76.94 | 3 | UCB, Inc. ($52.03) |
| 2019 | $301.85 | 11 | UCB, Inc. ($235.87) |
| 2018 | $246.66 | 9 | UCB, Inc. ($207.87) |
| 2017 | $490.96 | 15 | UCB, Inc. ($369.80) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.33 | General |
| Category: Neurology | ||||||
| 09/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.32 | General |
| Category: Neurology | ||||||
| 06/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $49.95 | General |
| Category: Neurology | ||||||
| 04/29/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $44.94 | General |
| Category: Neurology | ||||||
| 04/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Neurology | ||||||
| 07/24/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: Neurology | ||||||
| 06/22/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Neurology | ||||||
| 01/24/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Neurology | ||||||
| 01/05/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Neurology | ||||||
| 07/26/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 06/29/2022 | Stryker Corporation | NA (Device), ADHERUS AUTOSPRAY DURAL SEALANT | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 06/22/2022 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $39.82 | General |
| Category: Neurology | ||||||
| 05/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Diabetes | ||||||
| 12/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 11/30/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Neurology | ||||||
| 11/09/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $35.76 | General |
| Category: Neurology | ||||||
| 11/01/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Obesity | ||||||
| 10/11/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $38.17 | General |
| Category: Neurology | ||||||
| 09/01/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Neurology | ||||||
| 06/11/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Neurology | ||||||
| 04/30/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $36.38 | General |
| Category: Neurology | ||||||
| 04/13/2021 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Neurology | ||||||
| 03/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 02/23/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $40.36 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 147 | 170 | $155,891 | $12,566 |
| 2022 | 5 | 133 | 152 | $136,954 | $10,773 |
| 2021 | 5 | 189 | 227 | $170,579 | $15,631 |
| 2020 | 6 | 228 | 264 | $194,251 | $22,880 |
Total Patients
697
Total Services
813
Medicare Billing
$61,850
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 71 | $85,271 | $6,895 | 8.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $32,880 | $2,034 | 6.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 40 | $19,240 | $1,607 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $12,312 | $1,320 | 10.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 17 | $6,188 | $710.31 | 11.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 57 | $78,090 | $5,573 | 7.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 26 | 26 | $26,676 | $2,028 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 20 | $13,680 | $1,419 | 10.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 21 | 32 | $12,320 | $998.75 | 8.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 17 | $6,188 | $754.30 | 12.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 95 | 97 | $118,134 | $9,716 | 8.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 37 | 61 | $20,695 | $1,851 | 8.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 40 | $11,540 | $1,822 | 15.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 17 | $9,008 | $1,299 | 14.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $11,202 | $943.58 | 8.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 73 | 73 | $77,452 | $8,203 | 10.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 42 | 42 | $55,705 | $6,665 | 12.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 61 | $21,717 | $3,257 | 15.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 36 | 54 | $16,710 | $1,803 | 10.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 17 | 17 | $13,657 | $1,489 | 10.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 17 | $9,010 | $1,462 | 16.2% |
About Dr. Brett Osborn, DO
Dr. Brett Osborn, DO is a Neurological Surgery healthcare provider based in Jupiter, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932104049.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brett Osborn, DO has received a total of $1,870 in payments from pharmaceutical and medical device companies, with $197.36 received in 2024. These payments were reported across 64 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,870).
As a Medicare-enrolled provider, Osborn has provided services to 697 Medicare beneficiaries, totaling 813 services with total Medicare billing of $61,850. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Other Specialties Neurological Surgery
- Location Jupiter, FL
- Active Since 06/15/2005
- Last Updated 03/09/2015
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1932104049
Products in Payments
- Briviact (Drug) $1,158
- Vimpat (Drug) $217.64
- Posterior Fusion (Device) $101.75
- Nayzilam (Drug) $93.89
- NP Thyroid (Drug) $57.63
- Saxenda (Drug) $38.03
- Ozempic (Drug) $34.41
- Algovita (Device) $25.78
- NA (Device) $23.38
- CODMAN CERTAS (Device) $23.30
- RYBELSUS (Drug) $22.32
- Wegovy (Drug) $21.15
- Rybelsus (Drug) $21.12
- XYOSTED (Drug) $17.47
- ELIQUIS (Drug) $14.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.